ZA816124B - Pharmaceutical compositions for promoting the healing of wounds - Google Patents
Pharmaceutical compositions for promoting the healing of woundsInfo
- Publication number
- ZA816124B ZA816124B ZA816124A ZA816124A ZA816124B ZA 816124 B ZA816124 B ZA 816124B ZA 816124 A ZA816124 A ZA 816124A ZA 816124 A ZA816124 A ZA 816124A ZA 816124 B ZA816124 B ZA 816124B
- Authority
- ZA
- South Africa
- Prior art keywords
- wounds
- healing
- promoting
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8028554 | 1980-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA816124B true ZA816124B (en) | 1982-09-29 |
Family
ID=10515840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA816124A ZA816124B (en) | 1980-09-04 | 1981-09-03 | Pharmaceutical compositions for promoting the healing of wounds |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0047647B1 (it) |
| JP (1) | JPS5780316A (it) |
| AU (1) | AU7486081A (it) |
| BE (1) | BE890230A (it) |
| CA (1) | CA1198679A (it) |
| CH (1) | CH650148A5 (it) |
| DE (1) | DE3173310D1 (it) |
| DK (1) | DK390181A (it) |
| ES (1) | ES8307491A1 (it) |
| FI (1) | FI812708L (it) |
| FR (1) | FR2489145A1 (it) |
| GB (1) | GB2082911B (it) |
| IT (1) | IT1209894B (it) |
| NZ (1) | NZ198259A (it) |
| ZA (1) | ZA816124B (it) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0302536B1 (en) * | 1982-04-22 | 1992-11-19 | E.R. Squibb & Sons, Inc. | Granules for use in treating wounds |
| US4604384A (en) * | 1982-06-24 | 1986-08-05 | Smith Robert A | Pharmaceutical gel composition |
| GR79380B (it) * | 1982-09-28 | 1984-10-22 | Johnson & Johnson Prod Inc | |
| AU3298184A (en) * | 1983-09-13 | 1986-09-11 | Ed Giestlich Sohne A.G. Fur Chemische Industrie | Topically administrable pharmaceutical compositions |
| DD248961A1 (de) * | 1984-05-22 | 1987-08-26 | Akad Wissenschaften Ddr | Verfahren zur herstellung wundheilungsfoerdernder praeparationen |
| US5190916A (en) * | 1986-06-13 | 1993-03-02 | Japan Immuno Research Laboratories Co., Ltd. | Use of ovomacroglobulin as an agent for treating wound and inflammation |
| EP0321709A3 (en) * | 1987-12-23 | 1990-04-04 | Francisco José Izundegui MacDonnell | Fast healing and binding chemical compound or curative agent for healing wounded live animal and human soft tissues inflicted by cutting edges or separating forces |
| US4871718A (en) * | 1987-12-29 | 1989-10-03 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| GB2276819B (en) * | 1993-03-23 | 1996-12-11 | Johnson & Johnson Medical | Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol |
| US5670169A (en) * | 1993-12-20 | 1997-09-23 | E.R. Squibb & Sons, Inc. | Wound hydrating gel with novel preservative system and low cytotoxicity |
| GB2291348B (en) * | 1994-07-18 | 1999-01-20 | Johnson & Johnson Medical | Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol |
| WO1998043613A1 (fr) * | 1997-04-02 | 1998-10-08 | Tamaz Shalvovich Mchedlidze | Onguents pour traiter tous les stades de lesions suppuratives, brulures et ulcers trophiques, modes de preparation et applications |
| EP1228771A4 (en) | 1999-11-09 | 2003-01-29 | Denki Kagaku Kogyo Kk | USE OF SOLUBLE CELLULOSE DERIVATIVES MADE DIFFICULTLY SOLUBLE IN WATER AND METHOD OF PREPARING SUCH DERIVATIVES |
| WO2002094256A1 (en) * | 2001-05-23 | 2002-11-28 | Debatosh Datta | Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis |
| US10413528B2 (en) * | 2014-10-20 | 2019-09-17 | John H. Plumb | Methods to inhibit infection during wound healing with topical compositions including amino acids |
| JP2020531006A (ja) | 2017-08-18 | 2020-11-05 | カルウッド ニュートリショナルズ，エルエルーシー | 筋量および体力を増大させ、肌を処置し、加齢および暴露からの傷みおよび衰えを縮減し、運動および外傷などのストレスからの回復を改善するための組成物および方法 |
| RU2733714C2 (ru) * | 2017-11-07 | 2020-10-06 | Общество с ограниченной ответственностью "Трейдсервис" | Стабильная комбинированная фармацевтическая композиция диоксидина и анестетиков |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3786076A (en) * | 1966-10-13 | 1974-01-15 | J Morelle | Lipoaminoacids |
| JPS5233168B2 (it) * | 1973-01-08 | 1977-08-26 | ||
| FR2215212B1 (it) * | 1973-01-18 | 1976-03-05 | Seperic Ch | |
| DE2438703C3 (de) * | 1974-08-12 | 1980-02-21 | Ernst Dr.Med. 4970 Bad Oeynhausen Lauven | Verwendung einer Mischung bei der Rheumabehandlung |
| JPS5559106A (en) * | 1978-10-27 | 1980-05-02 | Shiseido Co Ltd | Oil-in-water type emulsion composition |
-
1981
- 1981-09-01 FR FR8116636A patent/FR2489145A1/fr active Granted
- 1981-09-02 FI FI812708A patent/FI812708L/fi not_active Application Discontinuation
- 1981-09-02 AU AU74860/81A patent/AU7486081A/en not_active Abandoned
- 1981-09-03 ES ES505172A patent/ES8307491A1/es not_active Expired
- 1981-09-03 JP JP56137858A patent/JPS5780316A/ja active Pending
- 1981-09-03 NZ NZ198259A patent/NZ198259A/xx unknown
- 1981-09-03 ZA ZA816124A patent/ZA816124B/xx unknown
- 1981-09-03 CA CA000385170A patent/CA1198679A/en not_active Expired
- 1981-09-03 IT IT8149222A patent/IT1209894B/it active
- 1981-09-03 CH CH5691/81A patent/CH650148A5/fr not_active IP Right Cessation
- 1981-09-03 DK DK390181A patent/DK390181A/da not_active Application Discontinuation
- 1981-09-04 EP EP81304053A patent/EP0047647B1/en not_active Expired
- 1981-09-04 DE DE8181304053T patent/DE3173310D1/de not_active Expired
- 1981-09-04 BE BE0/205872A patent/BE890230A/fr not_active IP Right Cessation
- 1981-09-04 GB GB8126836A patent/GB2082911B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES505172A0 (es) | 1983-07-01 |
| EP0047647A3 (en) | 1982-09-15 |
| ES8307491A1 (es) | 1983-07-01 |
| GB2082911A (en) | 1982-03-17 |
| EP0047647A2 (en) | 1982-03-17 |
| AU7486081A (en) | 1982-03-11 |
| CH650148A5 (fr) | 1985-07-15 |
| FI812708L (fi) | 1982-03-05 |
| GB2082911B (en) | 1984-04-18 |
| NZ198259A (en) | 1985-05-31 |
| JPS5780316A (en) | 1982-05-19 |
| CA1198679A (en) | 1985-12-31 |
| IT1209894B (it) | 1989-08-30 |
| DE3173310D1 (en) | 1986-02-06 |
| FR2489145A1 (fr) | 1982-03-05 |
| EP0047647B1 (en) | 1985-12-27 |
| FR2489145B1 (it) | 1984-05-25 |
| DK390181A (da) | 1982-03-05 |
| IT8149222A0 (it) | 1981-09-03 |
| BE890230A (fr) | 1982-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2188844B (en) | Pharmaceutical composition for the treatment of psoriasis | |
| DE3376957D1 (en) | Pharmaceutical gel composition | |
| EP0243002A3 (en) | Pharmaceutical composition for the treatment of periodontal diseases | |
| DE3173310D1 (en) | Pharmaceutical compositions for promoting the healing of wounds | |
| AU2199283A (en) | Pharmaceutical compositions of m-chloro-alpha-t- butylaminopropiophenone | |
| IL76561A (en) | Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases | |
| GB8327331D0 (en) | Application of surgical dressings | |
| GB2118176B (en) | Pharmaceutical compositions | |
| GB2117766B (en) | Pharmaceutical compositions | |
| GB8324133D0 (en) | Pharmaceutical compositions | |
| BG49522A1 (en) | Pharmaceutist composition accelarating the healing of mounds | |
| DE3261760D1 (en) | Pharmaceutical compositions for the treatment of skin | |
| GB8313814D0 (en) | Pharmaceutical compositions | |
| DE3174448D1 (en) | Combinations for the treatment of wounds | |
| DE3377696D1 (en) | Pharmaceutical compositions | |
| GB2124488B (en) | Agent for the treatment of wounds | |
| IT1159815B (it) | Composizione medicinale per il trattamento di certe neurovirosi | |
| GB2114001B (en) | Nasel pharmaceutical compositions | |
| EP0343671A3 (en) | Pharmaceutical composition for the treatment of skin wounds | |
| ZA837736B (en) | Application of surgical dressings | |
| ZA833997B (en) | Basic esters exhibiting an antagonistic activity to calcium,process for the preparation thereof and pharmaceutical compositions therefrom | |
| GB8305028D0 (en) | Pharmaceutical compositions | |
| ZA822176B (en) | Pharmaceutical compositions for the treatment of diabetes | |
| IL63593A0 (en) | Process for the preparation of new cytostatic compounds and pharmaceutical compositions containing them | |
| GB8312615D0 (en) | Compositions for treating infected burn wounds |